Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BASF Announces Up to 20% Price Increase for Excipients and APIs | Contract Pharma

What are you searching for?

Sign in
Breaking News

BASF Announces Up to 20% Price Increase for Excipients and APIs

Cites rising global energy and raw material costs.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

BASF Pharma Solutions has announced a global price increase for certain pharmaceutical excipients and selected active pharmaceutical ingredients (APIs), citing higher global energy and raw material costs.

According to the company, prices will rise by up to 20%, with increases taking effect immediately or as permitted under existing customer contracts. The adjustment applies to products supplied across BASF Pharma Solutions’ portfolio worldwide.

BASF said the pricing change is intended to support the continued supply of its pharmaceutical products amid ongoing cost pressures affecting manufacturing and sourcing. The company added that it will continue to assess market conditions and communicate any additional pricing changes if necessary.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics